Galleria mellonella in vitro model for chromoblastomycosis shows large differences in virulence between isolates

Dongmei Shi,Zhiya Yang,Wanqing Liao,Chen Liu,Liang Zhao,Huilin Su,Xiaodong Wang,Huan Mei,Min Chen,Yinggai Song,Sybren de Hoog,Shuwen Deng

DOI: https://doi.org/10.1186/s43008-023-00134-5

2024-03-09

IMA Fungus

Abstract:Chromoblastomycosis is the World Health Organization (WHO)-recognized fungal implantation disease that eventually leads to severe mutilation. Cladophialophora carrionii ( C. carrionii ) is one of the agents. However, the pathogenesis of C. carrionii is not fully investigated yet.

mycology

What problem does this paper attempt to address?

### What problems does this paper attempt to solve?

This paper aims to explore and solve the following problems:

1. **Understand the differences in pathogenicity among different strains**: Study the pathogenic potential of Cladophialophora carrionii (C. carrionii) and its closely related species Cladophialophora yegresii (C. yegresii) in the Galleria mellonella (greater wax moth larvae) infection model. By comparing clinical isolates and environmental isolates, reveal the differences in pathogenicity among different strains.

2. **Explore the effects of melanization and growth rate on pathogenicity**: Evaluate the effects of the degree of melanization and growth rate on the pathogenicity of C. carrionii and C. yegresii, and whether these characteristics are related to the clinical background of the strains.

3. **Evaluate the effectiveness of antifungal drugs**: Use the Galleria mellonella larvae model to evaluate the in vitro and in vivo efficacy of five antifungal drugs (amphotericin B, itraconazole, voriconazole, posaconazole, and terbinafine) against C. carrionii and C. yegresii, in order to explain the reasons for the limited clinical treatment effects.

4. **Reveal the differences in fungal infection behaviors**: By observing the morphological changes of the fungus in the Galleria mellonella larvae and the host immune response, reveal the behavioral differences of different strains during the infection process, including the distribution of the fungus in the host, morphological changes, and the host's immune response.

### Overview of research methods

- **Strain selection**: Six strains of C. carrionii and three strains of C. yegresii were selected for the study.
- **Determination of physiological parameters**: The growth rate and the degree of melanization at different temperatures were measured.
- **Galleria mellonella larvae infection model**: By injecting different concentrations of spore suspensions into Galleria mellonella larvae, the pathogenicity of the strains and the host survival rate were evaluated.
- **Antifungal drug testing**: The minimum inhibitory concentration (MIC) of five antifungal drugs and their protective effects on Galleria mellonella larvae infected were tested in vitro and in vivo respectively.
- **Histopathological analysis**: The distribution and morphological changes of the fungus in Galleria mellonella larvae and the host immune response were observed by microscope and PAS staining.

### Main conclusions

- **Significant differences in pathogenicity among strains**: There are significant differences in the pathogenicity of different strains, which are not related to the clinical background.
- **Melanization and growth rate affect pathogenicity**: Strains with a higher degree of melanization and growth rate show stronger pathogenicity.
- **Antifungal drugs have different efficacies**: Posaconazole and voriconazole show the best antifungal activity both in vitro and in vivo, while the efficacy of amphotericin B is limited.
- **Significant differences in infection behaviors**: Different strains show different behavioral patterns during the infection process, including differences in fungal morphological changes and host immune responses.

Through these studies, the authors hope to provide new insights into understanding the pathogenic mechanism of C. carrionii and provide references for the development of more effective treatment methods.